Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2025 Jul 1;25(1):256.
doi: 10.1186/s12883-025-04259-5.

An atypical presentation of infiltrative diffuse low-grade glioma in an adolescent: case report

Affiliations
Case Reports

An atypical presentation of infiltrative diffuse low-grade glioma in an adolescent: case report

Zoe Wolfenson et al. BMC Neurol. .

Abstract

Background: Diffuse low-grade gliomas (dLGG) are rare slow growing brain tumors. Symptoms associated with dLGG typically include seizures, hemiparesis, ataxia, behavioral changes, headaches, and tremors. In this study, we present the case of a thirteen-year-old male admitted to the National Institutes of Health (NIH) Undiagnosed Diseases Program (UDP). To the best of our knowledge, this is one of the only documented cases of an adult-type dLGG diagnosed in a pediatric patient with monitoring of tumor progression for nearly a decade prior to diagnosis.

Case presentation: The patient presented with a history of progressive signal abnormalities on brain magnetic resonance imaging (MRI), refractory to treatment attention deficit hyperactivity disorder (ADHD) and Oppositional Defiant Disorder (ODD), headaches, irritability, and difficulties sleeping. His detailed neurological exam was normal. Following six years of repeated MRI demonstrating increasing infiltrative tumor mass effect throughout gray and white matter, a brain biopsy was performed. The brain biopsy showed white and gray matter with mildly hypercellular areas, and tumor DNA sequencing showed the presence of a canonical IDH1 mutation. A "watch and wait" approach was adopted resulting from discussions between the patient and his family alongside the medical team with repeated quarterly brain MRI to monitor symptoms and tumor growth.

Conclusion: While behavioral and psychiatric changes are common in brain tumor patients, they typically present alongside neurological symptoms which emphasizes the difficulty in diagnosing cases like this patient's. Low-grade malignancies should be part of the differential diagnosis in cases with progressive multifocal white matter lesions, despite the absence of the typical neurological focal signs.

Keywords: Attention deficit hyperactivity disorder; Diffuse low-grade glioma; Magnetic resonance imaging; Undiagnosed diseases.

PubMed Disclaimer

Conflict of interest statement

Declarations. Ethical approval: This study was approved by the Institutional Review Board (IRB) of the National Institutes of Health (NIH), National Human Genome Research Institute (NHGRI). This study was carried out under NHGRI protocol 15-HG-0130. Clinical trial number: not applicable. Consent for publication: The patient provided informed written assent for this manuscript to be published. The patient’s guardian also provided informed written consent for this manuscript to be published after reviewing the manuscript. Competing interests: The authors declare no competing interests.

Figures

Fig. 1
Fig. 1
Imaging. Axial T2 (top two rows) and FLAIR (bottom two rows) MRI sequences at age 7 (A), 8 (B), 9 (C), 10 (D), 11 (E), 12 (F) and age 13 (G) of the patient at the level of insula (top row) and upper lateral ventricles (bottom row), respectively. There is progressive increase in mass effect of the infiltrative tumor throughout the white and gray matter of the insula and both the bilateral frontal and right temporal lobes. There was no Age 7 axial T2 scan, and the Age 9 FLAIR scan was severely motion distorted and not included

Similar articles

References

    1. Yeo KK, et al. Multi-institutional study of the frequency, genomic landscape, and outcome of IDH-mutant glioma in pediatrics. Neuro Oncol. 2023;25(1):199–210. - PMC - PubMed
    1. Louis DN, et al. The 2016 world health organization classification of tumors of the central nervous system: a summary. Acta Neuropathol. 2016;131(6):803–20. - PubMed
    1. Ranjan S, Warren KE. Gliomatosis cerebri: current Understanding and controversies. Front Oncol. 2017;7:165. - PMC - PubMed
    1. Louis DN, et al. The 2021 WHO classification of tumors of the central nervous system: a summary. Neuro Oncol. 2021;23(8):1231–51. - PMC - PubMed
    1. Taillibert S, et al. Gliomatosis cerebri: a review of 296 cases from the ANOCEF database and the literature. J Neurooncol. 2006;76(2):201–5. - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources